For ownersHealthcare services and technologyBefore the offer

You have a valuation. Now pressure-test the earnings behind it.

Find the financial gaps and earnings questions a buyer’s diligence will raise, while you still control the timeline. Your numbers traced to source documents, and a findings report that is yours to keep.

Request a pre-market review
Traced to source documents Findings you keep Nothing reaches a buyer without your permission
The gap between the valuation and the deal
57%

of dealmakers surveyed attributed failed deals in the first half of 2026 to valuation expectations. A year earlier it was 28 per cent.

Lower-middle-market dealmakers surveyed by a deal platform in July 2026, on deals that failed in the first half of the year, against 28 per cent for 2025. Published 11 August 2026.

What diligence finds

The findings that end deals are already in your records. Find them first.

Seventy-five letters of intent that were signed and then collapsed, with the reasons as reported. Each of these sits in records an owner already holds.

21.3%
The earnings were not what was presentedAdjusted EBITDA did not survive contact with the source documents. Twice the 2023 rate of 10.6 per cent.
25.3%
A finding outside the quality-of-earnings workA licence, a contract, a compliance gap, a customer concentration. Up from 19.1 per cent in 2023.
14.7%
The renegotiation that followedThe finding did not end the deal. The argument about the price after it did.
37–159
Average days under exclusivity before it diedFrom 37 days where a family office was the buyer to 159 where a senior lender was. The business is off the market the whole time.
The usual orderYour order
Today

The buyer’s quality of earnings is the first close reading of your numbers. It starts after the letter is signed and exclusivity has begun, when you have the least room to respond.

With a pre-market review

The same questions are answered before the first buyer call. You fix what can be fixed, document what cannot, and negotiate from numbers already traced to source.

A lower-middle-market deal platform’s published study of broken letters of intent, 27 January 2026: seventy-five broken letters across eight buyer types and eight industries, with 2023 comparisons from the same series. The percentages are separate reported categories and are not summed here. Exclusivity figures are averages by buyer type, not individual deals.

What the review covers

The questions a buyer’s quality of earnings will ask, answered on your side of the table.

PreQoE™ is non-attest preparation. It is not a quality of earnings report and it does not replace one. It shows you what that report is likely to find, while there is still time to act on it.

01
Earnings, traced

Revenue reconciled to bank deposits, and reported earnings tied to the records behind them.

02
Every adjustment, marked

Each add-back you or your adviser proposes is marked supported or unsupported, with the document that decides it.

03
Customers and payers

Concentration, retention and contract terms, read the way a buyer will read them.

04
Contracts and licences

Assignability, change-of-control terms, and the compliance items a buyer’s counsel will ask about.

05
A findings report and workbook

What was found, what it affects, and what to fix first. Yours to keep.

How it works

Three steps, and you decide what happens after each one.

1A conversation

About the business, its market and your timing. No documents, no charge and no obligation.

2The review

Starts with an agreed information request under a signed NDA. Scope and fee are set in writing before any work begins.

3The findings

A report and workbook you keep. Act on it, wait, or hand it to your own adviser.

YouDecide what is next

Sell now, sell later or keep building. The review is useful whichever you choose.

No valuation yet

Know your earnings. Before you negotiate your price.

The Pre-Market Assessment is the wider starting point: three working sessions, a written assessment and a 90-day plan, for owners who want to grow now and keep their options open. You do not need to have decided to sell.

Talk to us about an assessment
When you are ready

Your findings stay yours. So does the decision to sell.

When you decide to go to market, representation is arranged through a sell-side partner under its own engagement. Nothing from your review reaches a buyer, or anyone else, without your written permission.

What we will not do
01Share your findings without written permission 02Act for both sides of your transaction 03Ask for a listing agreement to start 04Promise you a price

Anyone who puts a number on what preparation adds to a price is quoting their own marketing. What a review does is show what your numbers support, and give you the chance to fix what they do not before a buyer prices it.

For advisers and CPAs

Bring your client in before the buyer’s quality of earnings does.

M&A advisersAnswer the earnings questions before they disrupt the deal.

Your seller arrives at the letter of intent with the add-backs already marked and the gaps already known. The engagement is with your client, and you stay the adviser.

CPAs and accountantsYour client, your engagement, our record.

Non-attest work only. We take no fee of any kind on attested work, in any direction. If your client needs an audit, review, compilation or attestation, that goes to an independent firm.

Refer a client
The questions owners ask

Plain answers, before you ask.

Is this a quality of earnings report?

No. It is non-attest preparation for the questions a buyer’s quality of earnings will ask. It is not an audit, review, compilation or attestation, and it does not replace the report a buyer or lender commissions.

Will it raise my price?

We will not promise that. It shows what your numbers support, and gives you the chance to fix what they do not, before a buyer prices it.

Who sees the findings?

You. Nothing reaches a buyer, an adviser or anyone else without your written permission.

What do you need from me?

To start, a conversation. The review itself begins with an agreed information request under a signed NDA. Patient records and protected health information are never requested.

What does it cost?

The scope and the fee are agreed in writing before any work begins, once we know what the business needs.

Request a review

Know what a buyer will find, before the buyer does.

Capital Row is the M&A firm that reads your numbers the way a buyer will, before you go to market. Every figure traced to a source document, every adjustment marked supported or unsupported, and the findings are yours to keep.

Never both sides of the same transaction

Tell us what you are working on.

Tell us what you are working on and where you need clarity. We will respond to discuss fit and the next step.

Please do not send financial documents, PHI or confidential information here. Sensitive information moves through a controlled workspace, under a signed engagement letter.

Or write to the desk directly at team@thecapitalrow.com